Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Young-A Heo

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Drugs|December 2, 2022
Pegcetacoplan: A Review in Paroxysmal Nocturnal HaemoglobinuriaYoung-A Heo
Drugs & Therapy Perspectives : for Rational Drug Selection and Use|November 22, 2018
Andexanet alfa in the treatment of acute major bleeding related to apixaban and rivaroxaban: a profile of its use in the USAYoung-A Heo
Drugs|February 25, 2021
Imipenem/Cilastatin/Relebactam: A Review in Gram-Negative Bacterial InfectionsYoung-A Heo
Drugs|January 19, 2023
Mirvetuximab Soravtansine: First ApprovalYoung-A Heo
Drugs|September 9, 2020
Correction to: Satralizumab: First ApprovalYoung-A Heo
Drugs|March 30, 2022
Correction to: Efgartigimod: First ApprovalYoung-A Heo
CNS Drugs|March 31, 2023
Efgartigimod Alfa in Generalised Myasthenia Gravis: A Profile of Its UseYoung-A Heo
Drugs|August 28, 2021
Correction to: Budesonide/Glycopyrronium/Formoterol: A Review in COPDYoung-A Heo
Drugs|February 28, 2024
Apadamtase Alfa: First ApprovalYoung-A Heo
Drugs|August 3, 2021
Budesonide/Glycopyrronium/Formoterol: A Review in COPDYoung-A Heo
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Drugs|December 2, 2022
Pegcetacoplan: A Review in Paroxysmal Nocturnal HaemoglobinuriaYoung-A Heo
Drugs & Therapy Perspectives : for Rational Drug Selection and Use|November 22, 2018
Andexanet alfa in the treatment of acute major bleeding related to apixaban and rivaroxaban: a profile of its use in the USAYoung-A Heo
Drugs|February 25, 2021
Imipenem/Cilastatin/Relebactam: A Review in Gram-Negative Bacterial InfectionsYoung-A Heo
Drugs|January 19, 2023
Mirvetuximab Soravtansine: First ApprovalYoung-A Heo
Drugs|September 9, 2020
Correction to: Satralizumab: First ApprovalYoung-A Heo
Drugs|March 30, 2022
Correction to: Efgartigimod: First ApprovalYoung-A Heo
CNS Drugs|March 31, 2023
Efgartigimod Alfa in Generalised Myasthenia Gravis: A Profile of Its UseYoung-A Heo
Drugs|August 28, 2021
Correction to: Budesonide/Glycopyrronium/Formoterol: A Review in COPDYoung-A Heo
Drugs|February 28, 2024
Apadamtase Alfa: First ApprovalYoung-A Heo
Drugs|August 3, 2021
Budesonide/Glycopyrronium/Formoterol: A Review in COPDYoung-A Heo
Pageof 6